32 results
8-K
APLS
Apellis Pharmaceuticals Inc
29 Aug 23
Cost Associated with Exit or Disposal Activities
7:05am
that the Company’s restructuring efforts may negatively impact its business operations and reputation; the risk that the Company’s restructuring efforts
8-K
EX-10.1
62w d47jq9ajeb3
7 Oct 19
Departure of Directors or Certain Officers
4:06pm